Mitochondria targeting molecular transporters: synthesis, lipophilic effect, and ionic complex

Area of Science:

• Biomedical Engineering
• Mitochondrial Biology
• Drug Delivery Systems

Background:

• Mitochondria are key targets for treating human diseases.
• Delivering therapeutic agents to mitochondria offers new treatment avenues.
• Developing efficient mitochondria-targeting vectors is crucial for drug delivery.

Purpose of the Study:

• To synthesize and evaluate novel sorbitol-based molecular transporters for mitochondrial targeting.
• To enhance the targeting efficiency of molecular transporters by incorporating lipophilic groups.
• To assess the potential of these transporters as drug delivery vectors for mitochondrial dysfunction.

Main Methods:

• Synthesis of sorbitol-based molecular transporters with guanidine groups.
• Measurement of partition coefficients to assess lipophilicity.
• Evaluation of mitochondrial targeting efficiency using fluorescent imaging and Pearson's correlation coefficients.
• Investigation of cellular uptake mechanisms.
• Complexation with antibiotics to assess therapeutic potential.

Main Results:

• Sorbitol-based transporters with guanidines were successfully synthesized.
• Attachment of an alanine-naphthalene lipophilic group significantly improved cellular membrane translocation and mitochondrial accumulation.
• The modified transporter formed ionic complexes with antibiotics, leading to reduced cell viability.
• Demonstrated efficient targeting and accumulation within mitochondria.

Conclusions:

• The developed sorbitol-based molecular transporter, enhanced with a lipophilic group, shows significant potential for targeted mitochondrial drug delivery.
• This novel vector can effectively deliver therapeutic payloads to mitochondria, addressing mitochondrial dysfunction.
• The findings support the use of this molecular transporter as a promising strategy for developing new treatments for mitochondrial diseases.